A phase I multiple ascending dose (SAD) trial of SAGE 718 in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 08 Jan 2018
At a glance
- Drugs SAGE 718
- Indications Smith-Lemli-Opitz syndrome
- Focus Adverse reactions
- 08 Jan 2018 According to a Sage Therapeutics media release, initiation of this multiple ascending dose study is anticipated in 1H 2018.
- 08 Nov 2017 New trial record
- 02 Nov 2017 According to a Sage Therapeutics media release, data readout from this trial is epxected in the second half of 2018.